Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:1014 Rivaoxaban Assay
Search Links: General Info : Protocols : Patient Info

Description Rivaoxaban is a new generation oral anticoagulant designed to replace wafarin therapy. The anti-factor Xa assay is used to monitor Rivaoxaban.
Indication Patients on Rivaoxaban therapy.
Additional Info Rivaoxaban therapy does not usually require monitoring. Some patients however (eg. Children, pregnancy, compliance confirmation) may require levels to be monitored.
Concurrent Testsna
Dietary Requirementsna

Interpretation Interpreted against a therapeutic range dependent on clinical details

Ref. Range (Male)
Ref. Range (Female)
Ref. Range (Paed)
Ref. Range NotesInterpreted against a therapeutic range dependent on clinical details Critical telephone values: Rivaroxaban anti-Xa greater than 550ng/mL

Other Help:National Laboratory Medicine Handbook

IP Acute TAT- Not Defined -
IP Routine TAT24 hours
GP Acute TAT- Not Defined -
GP Routine TAT24 hours
Turnround CommentSpecialist test only to be requested by a medical haematologist.
Originally edited by : RJAR. Last edited on 18/06/2019 10:38:43. Published By RJAR on 18/06/2018 10:38:43.